glp 1 agonist saxenda Order Pens (Liraglutide) from Canada Oral GLP-1 weight loss medication
Description
Saxenda may require long-term use
However, the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) trial found that the once-daily GLP-1 receptor agonist lixisenatide had a neutral effect on cardiovascular outcomes, neither increasing nor decreasing incidence relative to placebo (31)
ACG Clinical Guideline: Gastroparesis
during the conduct of the study
Liu L, Shi H, Shi Y, Wang A, Guo N, Tao H, et al
